Graham Capital Management, L.P. Arcturus Therapeutics Holdings Inc. Transaction History

Graham Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $84,795 - $157,860	4,788 Added 56.03%	13,334 $420,000
Q3 2023 Nov 22, 2023	BUY	$25.44 - $37.35 $217,410 - $319,193	8,546 New	8,546 $218,000
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $1.92 Million - $3.13 Million	-74,262 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $2.1 Million - $4.72 Million	54,262 Added 271.31%	74,262 $3.07 Million
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $692,200 - $2.47 Million	20,000 New	20,000 $867,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $439M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.